Things are about to look up for a FTSE 100 utilities firm for the first time in 10 years. So should investors jump on the ...

The iShares MSCI Emerging Markets ETF (NYSE:EEM) surged 39% in 2025 and added another 3.9% in the first week of 2026. The ...

Hans-Jörg Rudloff was a leading banker in the international bond market at a time when a single individual could still shape ...

Goldman Sachs once again dominated the league tables for global dealmaking in 2025, taking market share and the top spot in a ...

But let's suppose JPMorgan achieves the upper margin target of $22.93 for 2026 and the company pays that premium due to the ...

The country is more than halfway through an economic plan to reduce its dependence on oil Read more at The Business Times.

Goldman ranked No. 1 in two key areas: M&A fee revenue and overall value of the deals ​it worked on, gaining market ⁠share in ...

Let's return to our initial question: Should you buy stocks if a recession is coming in 2026? If history is an guide, the ...

JPMorgan Large Cap Growth JLGMX benefits from a veteran leader and a solid supporting cast, leveraging thorough fundamental ...

Aktis Oncology, Inc. targets $200M IPO to advance radiopharmaceuticals for solid tumors. Click for more on the upcoming AKTS ...

Patrice Motsepe’s leadership aligns with many of John C. Maxwell’s principles, particularly regarding influence, people development, and a strong sense of purpose. His style is generally described as ...

Vella Bioscience, a pioneering FemTech company advancing clinically driven solutions in women's hormonal, sexual, and intimate health, today announced the appointment of Joy Allen-Altimare as ...